Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam in NASH
NCT01066364Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Feb 2010
- Primary completion
- Feb 2012
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of colesevelam in Nonalcoholic steatohepatitis (NASH), sponsored by University of California, San Diego. Started Feb 2010; status: completed.
02
Drugs
colesevelam
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01066364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066364.